Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy
Alberto G. Conti(University of Cambridge), Rahul Roychoudhuri(University of Cambridge)
Cited by 8
Related Papers
BACH2 regulates CD8+ T cell differentiation by controlling access of AP-1 factors to enhancers
|Nature Immunology|2016|329
Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infection
|The Journal of Experimental Medicine|2015|258